Cargando…
Forty‐three key gene expressions involved in the effect of indoleamine 2,3‐dioxygenase 1 expression on cancer prognosis may be a potential indoleamine 2,3‐dioxygenase 1 inhibitor biomarker
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7888544/ https://www.ncbi.nlm.nih.gov/pubmed/33634987 http://dx.doi.org/10.1002/ctm2.330 |
_version_ | 1783652184809799680 |
---|---|
author | Li, Weirui Guo, Leilei Xing, Zikang Fang, Xin Liang, Heng Zhang, Shengnan Shi, Lei Kuang, Chunxiang Shi, Leming Zheng, Yuanting Hu, Yueqing Yang, Qing |
author_facet | Li, Weirui Guo, Leilei Xing, Zikang Fang, Xin Liang, Heng Zhang, Shengnan Shi, Lei Kuang, Chunxiang Shi, Leming Zheng, Yuanting Hu, Yueqing Yang, Qing |
author_sort | Li, Weirui |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7888544 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78885442021-02-26 Forty‐three key gene expressions involved in the effect of indoleamine 2,3‐dioxygenase 1 expression on cancer prognosis may be a potential indoleamine 2,3‐dioxygenase 1 inhibitor biomarker Li, Weirui Guo, Leilei Xing, Zikang Fang, Xin Liang, Heng Zhang, Shengnan Shi, Lei Kuang, Chunxiang Shi, Leming Zheng, Yuanting Hu, Yueqing Yang, Qing Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2021-02-17 /pmc/articles/PMC7888544/ /pubmed/33634987 http://dx.doi.org/10.1002/ctm2.330 Text en © 2021 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Letter to Editor Li, Weirui Guo, Leilei Xing, Zikang Fang, Xin Liang, Heng Zhang, Shengnan Shi, Lei Kuang, Chunxiang Shi, Leming Zheng, Yuanting Hu, Yueqing Yang, Qing Forty‐three key gene expressions involved in the effect of indoleamine 2,3‐dioxygenase 1 expression on cancer prognosis may be a potential indoleamine 2,3‐dioxygenase 1 inhibitor biomarker |
title | Forty‐three key gene expressions involved in the effect of indoleamine 2,3‐dioxygenase 1 expression on cancer prognosis may be a potential indoleamine 2,3‐dioxygenase 1 inhibitor biomarker |
title_full | Forty‐three key gene expressions involved in the effect of indoleamine 2,3‐dioxygenase 1 expression on cancer prognosis may be a potential indoleamine 2,3‐dioxygenase 1 inhibitor biomarker |
title_fullStr | Forty‐three key gene expressions involved in the effect of indoleamine 2,3‐dioxygenase 1 expression on cancer prognosis may be a potential indoleamine 2,3‐dioxygenase 1 inhibitor biomarker |
title_full_unstemmed | Forty‐three key gene expressions involved in the effect of indoleamine 2,3‐dioxygenase 1 expression on cancer prognosis may be a potential indoleamine 2,3‐dioxygenase 1 inhibitor biomarker |
title_short | Forty‐three key gene expressions involved in the effect of indoleamine 2,3‐dioxygenase 1 expression on cancer prognosis may be a potential indoleamine 2,3‐dioxygenase 1 inhibitor biomarker |
title_sort | forty‐three key gene expressions involved in the effect of indoleamine 2,3‐dioxygenase 1 expression on cancer prognosis may be a potential indoleamine 2,3‐dioxygenase 1 inhibitor biomarker |
topic | Letter to Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7888544/ https://www.ncbi.nlm.nih.gov/pubmed/33634987 http://dx.doi.org/10.1002/ctm2.330 |
work_keys_str_mv | AT liweirui fortythreekeygeneexpressionsinvolvedintheeffectofindoleamine23dioxygenase1expressiononcancerprognosismaybeapotentialindoleamine23dioxygenase1inhibitorbiomarker AT guoleilei fortythreekeygeneexpressionsinvolvedintheeffectofindoleamine23dioxygenase1expressiononcancerprognosismaybeapotentialindoleamine23dioxygenase1inhibitorbiomarker AT xingzikang fortythreekeygeneexpressionsinvolvedintheeffectofindoleamine23dioxygenase1expressiononcancerprognosismaybeapotentialindoleamine23dioxygenase1inhibitorbiomarker AT fangxin fortythreekeygeneexpressionsinvolvedintheeffectofindoleamine23dioxygenase1expressiononcancerprognosismaybeapotentialindoleamine23dioxygenase1inhibitorbiomarker AT liangheng fortythreekeygeneexpressionsinvolvedintheeffectofindoleamine23dioxygenase1expressiononcancerprognosismaybeapotentialindoleamine23dioxygenase1inhibitorbiomarker AT zhangshengnan fortythreekeygeneexpressionsinvolvedintheeffectofindoleamine23dioxygenase1expressiononcancerprognosismaybeapotentialindoleamine23dioxygenase1inhibitorbiomarker AT shilei fortythreekeygeneexpressionsinvolvedintheeffectofindoleamine23dioxygenase1expressiononcancerprognosismaybeapotentialindoleamine23dioxygenase1inhibitorbiomarker AT kuangchunxiang fortythreekeygeneexpressionsinvolvedintheeffectofindoleamine23dioxygenase1expressiononcancerprognosismaybeapotentialindoleamine23dioxygenase1inhibitorbiomarker AT shileming fortythreekeygeneexpressionsinvolvedintheeffectofindoleamine23dioxygenase1expressiononcancerprognosismaybeapotentialindoleamine23dioxygenase1inhibitorbiomarker AT zhengyuanting fortythreekeygeneexpressionsinvolvedintheeffectofindoleamine23dioxygenase1expressiononcancerprognosismaybeapotentialindoleamine23dioxygenase1inhibitorbiomarker AT huyueqing fortythreekeygeneexpressionsinvolvedintheeffectofindoleamine23dioxygenase1expressiononcancerprognosismaybeapotentialindoleamine23dioxygenase1inhibitorbiomarker AT yangqing fortythreekeygeneexpressionsinvolvedintheeffectofindoleamine23dioxygenase1expressiononcancerprognosismaybeapotentialindoleamine23dioxygenase1inhibitorbiomarker |